Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 10 of 13 entries
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Adrenergic signaling in cardiomyocytes 💬 27 genes, 80 drugs (DrugBank) and 71 diseases |
ADRB2 1件: ADRB2 💬Adrenergic signaling in cardiomyocytes
|
Albuterol Albuterol 💬Adrenergic signaling in cardiomyocytes
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬1. Adrenergic signaling in cardiomyocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Calcium signaling pathway 💬 79 genes, 187 drugs (DrugBank) and 134 diseases |
ADRB2 1件: ADRB2 💬Calcium signaling pathway
|
Albuterol Albuterol 💬Calcium signaling pathway
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬2. Calcium signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 3 | cAMP signaling pathway 💬 67 genes, 171 drugs (DrugBank) and 114 diseases |
ADRB2 1件: ADRB2 💬cAMP signaling pathway
|
Albuterol Albuterol 💬cAMP signaling pathway
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬3. cAMP signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 4 | cGMP-PKG signaling pathway 💬 46 genes, 119 drugs (DrugBank) and 118 diseases |
ADRB2 1件: ADRB2 💬cGMP-PKG signaling pathway
|
Albuterol Albuterol 💬cGMP-PKG signaling pathway
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬4. cGMP-PKG signaling pathway
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Chemical carcinogenesis - receptor activation 💬 39 genes, 126 drugs (DrugBank) and 116 diseases |
ADRB2 1件: ADRB2 💬Chemical carcinogenesis - receptor activation
|
Albuterol Albuterol 💬Chemical carcinogenesis - receptor activation
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬5. Chemical carcinogenesis - receptor activation
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Cortisol synthesis and secretion 💬 15 genes, 33 drugs (DrugBank) and 61 diseases |
KCNA4 1件: KCNA4 💬Cortisol synthesis and secretion
|
Amifampridine Amifampridine 💬Cortisol synthesis and secretion
| Amifampridine | 003 3件: 3 , 11, 12 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Cushing syndrome 💬 24 genes, 50 drugs (DrugBank) and 66 diseases |
KCNA4 1件: KCNA4 💬Cushing syndrome
|
Amifampridine Amifampridine 💬Cushing syndrome
| Amifampridine | 003 3件: 3 , 11, 12 💬
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Neuroactive ligand-receptor interaction 💬 149 genes, 320 drugs (DrugBank) and 153 diseases |
ADRB2 1件: ADRB2 💬Neuroactive ligand-receptor interaction
|
Albuterol Albuterol 💬Neuroactive ligand-receptor interaction
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬8. Neuroactive ligand-receptor interaction
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 69 diseases |
ADRB2 1件: ADRB2 💬Regulation of lipolysis in adipocytes
|
Albuterol Albuterol 💬Regulation of lipolysis in adipocytes
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬9. Regulation of lipolysis in adipocytes
|
|||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Renin secretion 💬 28 genes, 82 drugs (DrugBank) and 107 diseases |
ADRB2 1件: ADRB2 💬Renin secretion
|
Albuterol Albuterol 💬Renin secretion
| Salbutamol | 003 12件: 3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬10. Renin secretion
|